EverSource Wealth Advisors’s iTeos Therapeutics ITOS Stock Holding History

EverSource Wealth Advisors’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-636	Closed	-$6.34K	–	4405
2025 Q2	$6.34K	Buy	636 +548	+623%	+$4.41K	﹤0.01%	3053
2025 Q1	$526	Buy	88 +3	+4%	+$22	﹤0.01%	3441
2024 Q4	$653	Sell	85 -85	-50%	-$730	﹤0.01%	3103
2024 Q3	$1.74K	Hold	170	–	–	﹤0.01%	2582
2024 Q2	$2.99K	Hold	170	–	–	﹤0.01%	2414
2024 Q1	$1.83K	Sell	170 -282	-62%	-$3.07K	﹤0.01%	2417
2023 Q4	$4.95K	Buy	+452	New	+$4.48K	﹤0.01%	1865

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors's ITOS Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 636 shares — an estimated $6.34K sold.

EverSource Wealth Advisors first reported a position in ITOS in Q4 2023 and held it in 7 quarters. The position peaked at $6.34K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

EverSource Wealth Advisors reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
EverSource Wealth Advisors sold 636 iTeos Therapeutics shares in Q3 2025, an estimated $6.34K.
EverSource Wealth Advisors first reported a position in iTeos Therapeutics in Q4 2023 and held it in 7 quarters.
EverSource Wealth Advisors's iTeos Therapeutics position peaked at $6.34K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.